High-salt intake primes the rat kidney to respond to a subthreshold uroguanylin dose during ex vivo renal perfusion

Regulatory Peptides

Volumn 158, Issue 1-3, 2009, Pages 6-13

  Fonteles, Manassés C ^a,b,c   Havt, A ^a   Prata, Rodrigo B ^a   Prata, Patrícia H B ^a   Monteiro, Helena S A ^a   Lima, Aldo A M ^a   Jorge, Antônio R C ^a   Santos, Cláudia F ^c   Greenberg, Richard N ^d,e   Nascimento, Nilberto R F ^c  

^a Center for Global Health   (Brazil)

^b MACKENZIE PRESBYTERIAN UNIVERSITY   (Brazil)

^c STATE UNIVERSITY OF CEARÁ   (Brazil)

^d UNIVERSITY OF KENTUCKY   (United States)

^e LEXINGTON VA MEDICAL CENTER   (United States)

Author keywords

Guanylate cyclase C; Intestinal natriuretic peptide; Salt metabolism

Indexed keywords

CHLORINE; GUANYLATE CYCLASE; GUANYLYL CYCLASE A RECEPTOR; GUANYLYL CYCLASE C RECEPTOR; HORMONE RECEPTOR; POTASSIUM ION; SODIUM CHLORIDE; SODIUM ION; UNCLASSIFIED DRUG; UROGUANYLIN; WATER;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DOWN REGULATION; EX VIVO STUDY; GENE EXPRESSION; ISOLATED KIDNEY; KIDNEY PERFUSION; MICTURITION; NONHUMAN; POTASSIUM EXCRETION; PRIORITY JOURNAL; RAT; SALT INTAKE; SODIUM EXCRETION; UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; DNA PRIMERS; KIDNEY; NATRIURETIC PEPTIDES; PERFUSION; RATS; RATS, INBRED WKY; SODIUM CHLORIDE, DIETARY;

ANIMALIA; ENA; RATTUS;

EID: 70349731455     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.07.011     Document Type: Article

References (41)

1. Lennane R.J., Carey R.M., Goodwin T.J., and Peart W.S. A comparison of natriuresis after oral and intravenous sodium loading in sodium-depleted man: evidence for a gastrointestinal or portal monitor of sodium intake. Clin Sci Mol Med 49 (1975) 437-440
2. Currie M.G., Fok K.F., Kato J., Moore R.J., Hamra F.K., Duffin K.L., et al. Guanylin: an endogenous activator of intestinal guanylate cyclase. Proc Natl Acad Sci U S A 89 (1992) 947-951
3. Forte Jr. L.R. Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics. Pharmacol Ther 104 (2004) 137-162
4. Hamra F.K., Forte L.R., Eber S.L., Pidhorodeckyj N.V., Krause W.J., Freeman R.H., et al. Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase. Proc Natl Acad Sci U S A 90 (1993) 10464-10468
5. Hughes J.M., Murad F., Chang B., and Guerrant R.L. Role of cyclic GMP in the action of heat-stable enterotoxin of Escherichia coli. Nature 271 (1978) 755-756
6. Lima A.A., Monteiro H.S., and Fonteles M.C. The effects of Escherichia coli heat-stable enterotoxin in renal sodium tubular transport. Pharmacol Toxicol 70 (1992) 163-167
7. Forte Jr. L.R. Uroguanylin: physiological role as a natriuretic hormone. J Am Soc Nephrol 16 (2005) 291-292
8. Carrithers S.L., Jackson B.A., Cai W.Y., Greenberg R.N., and Ott C.E. Site-specific effects of dietary salt intake on guanylin and uroguanylin mRNA expression in rat intestine. Regul Pept 107 (2002) 87-95
9. Potthast R., Ehler E., Scheving L.A., Sindic A., Schlatter E., and Kuhn M. High salt intake increases uroguanylin expression in mouse kidney. Endocrinology 142 (2001) 3087-3097
10. Kinoshita H., Fujimoto S., Fukae H., Yokota N., Hisanaga S., Nakazato M., et al. Plasma and urine levels of uroguanylin, a new natriuretic peptide, in nephrotic syndrome. Nephron 81 (1999) 160-164
11. Kinoshita H., Fujimoto S., Nakazato M., Yokota N., Date Y., Yamaguchi H., et al. Urine and plasma levels of uroguanylin and its molecular forms in renal diseases. Kidney Int 52 (1997) 1028-1034
12. Kinoshita H., Nakazato M., Yamaguchi H., Matsukura S., Fujimoto S., and Eto T. Increased plasma guanylin levels in patients with impaired renal function. Clin Nephrol 47 (1997) 28-32
13. Nakazato M., Yamaguchi H., Kinoshita H., Kangawa K., Matsuo H., Chino N., et al. Identification of biologically active and inactive human uroguanylins in plasma and urine and their increases in renal insufficiency. Biochem Biophys Res Commun 220 (1996) 586-593
14. Fukae H., Kinoshita H., Fujimoto S., Kita T., Nakazato M., and Eto T. Changes in urinary levels and renal expression of uroguanylin on low or high salt diets in rats. Nephron 92 (2002) 373-378
15. Greenberg R.N., Hill M., Crytzer J., Krause W.J., Eber S.L., Hamra F.K., et al. Comparison of effects of uroguanylin, guanylin, and Escherichia coli heat-stable enterotoxin STa in mouse intestine and kidney: evidence that uroguanylin is an intestinal natriuretic hormone. J Investig Med 45 (1997) 276-282
16. Fonteles M.C., Greenberg R.N., Monteiro H.S., Currie M.G., and Forte L.R. Natriuretic and kaliuretic activities of guanylin and uroguanylin in the isolated perfused rat kidney. Am J Physiol 275 (1998) F191-F197
17. Lorenz J.N., Nieman M., Sabo J., Sanford L.P., Hawkins J.A., Elitsur N., et al. Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enteral NaCl load. J Clin Invest 112 8 (2003) 1244-1254
18. Quian X., Moss N.G., Fellner R.C., and Goy M.F. Circulating prouroguanylin is processed to its active natriuretic form exclusively within the renal tubules. Endocrinology 149 (2008) 4499-4509
19. Moss N.G., Fellner R.C., Qian X., Yu S.J., Li Z., Nakazato M., et al. Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide. Endocrinology 149 9 (2008) 4486-4498
20. Kikuchi M., Fujimoto S., Fukae H., Kinoshita H., Kita T., Nakazato M., et al. Role of uroguanylin, a peptide with natriuretic activity, in rats with experimental nephrotic syndrome. J Am Soc Nephrol 16 (2005) 392-397
21. Carrithers S.L., Eber S.L., Forte L.R., and Greenberg R.N. Increased urinary excretion of uroguanylin in patients with congestive heart failure. Am J Physiol Heart Circ Physiol 278 (2000) H538-H547
22. Fukae H., Kinoshita H., Fujimoto S., Nakazato M., and Eto T. Plasma concentration of uroguanylin in patients on maintenance dialysis therapy. Nephron 84 (2000) 206-210
23. Forte L.R., London R.M., Freeman R.H., and Krause W.J. Guanylin peptides: renal actions mediated by cyclic GMP. Am J Physiol Renal Physiol 278 (2000) F180-F191
24. Carrithers S.L., Ott C.E., Hill M.J., Johnson B.R., Cai W., Chang J.J., et al. Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor. Kidney Int 65 (2004) 40-53
25. Sindic A., and Schlatter E. Celular effects of guanylin and uroguanylin. J Am Soc Nephrol 17 (2006) 607-616
26. Santos-Neto M.S., Carvalho A.F., Monteiro H.S., Forte L.R., and Fonteles M.C. Interaction of atrial natriuretic peptide, urodilatin, guanylin and uroguanylin in the isolated perfused rat kidney. Regul Pept 136 (2006) 14-22
27. Bowman R.H. Gluconeogenesis in the isolated perfused rat kidney. J Biol Chem 245 (1970) 1604-1612
28. Fonteles M.C., Cohen J.J., Black A.J., and Wertheim S.J. Support of kidney function by long-chain fatty acids derived from renal tissue. Am J Physiol 244 (1983) F235-F246
29. Martinez-Maldonado M., and Opava-Stitzer S. Free water clearance curves during saline, mannitol, glucose and urea diuresis in the rat. J Physiol 280 (1978) 487-497
30. Walser M., Davidson D.G., and Orloff J. The renal clearance of alkali-stable inulin. J Clin Invest 34 (1955) 1520-1523
31. Fonteles M.C., Carrithers S.L., Monteiro H.S., Carvalho A.F., Coelho G.R., Greenberg R.N., et al. Renal effects of serine-7 analog of lymphoguanylin in ex vivo rat kidney. Am J Physiol Renal Physiol 280 (2001) F207-F213
32. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 9 (2001 May 1) e45
33. Amorim J.B., Musa-Aziz R., Lessa L.M., Malnic G., and Fonteles M.C. Effect of uroguanylin on potassium and bicarbonate transport in rat renal tubules. Can J Physiol Pharmacol 84 10 (2006) 1003-1010
34. Kuhn M. Cardiac and intestinal natriuretic peptides: insights from genetically modified mice. Peptides 26 (2005) 1078-1085
35. Sindic A., and Schlatter E. Mechanisms of action of uroguanylin and guanylin and their role in salt handling. Nephrol Dial Transplant 21 (2006) 3007-3012
36. Lee K.S., Kim S.Y., Han J.H., Kim Y.A., Cao C., Kim S.Z., et al. Different responses of atrial natriuretic peptide secretion and its receptor density to salt intake in rats. Exp Biol Med (Maywood) 229 1 (2004) 65-71
37. Deloof S., De Seze C., Montel V., and Chatelain A. Atrial natriuretic peptide and aldosterone secretions, and atrial natriuretic peptide-binding sites in kidneys and adrenal glands of pregnant and fetal rats in late gestation in response to a high-salt diet. Eur J Endocrinol 142 (2000) 524-532
38. Dubois S.K., Kishimoto I., Lillis T.O., and Garbers D.L. A genetic model defines the importance of the atrial natriuretic peptide receptor (guanylyl cyclase-A) in the regulation of kidney function. Proc Natl Acad Sci U S A 97 (2000) 4369-4373
39. Hong M., Jin Y., Mai Y.Q., and Han K.K. The effects of salt-loading and dehydration on atrial natriuretic peptide (ANP) gene expression. Comp Biochem Physiol B 97 (1990) 205-208
40. Gauquelin G., Garcia R., Carrier F., Cantin M., Gutkowska J., Thibault G., and Schiffrin E.L. Glomerular ANF receptor regulation during changes in sodium and water metabolism. Am J Physiol 254 (1988) F51-F55
41. Baba A., Fujimoto S., Kikuchi M., Kita T., and Kitamura K. Effects of uroguanylin on natriuresis in experimental nephrotic rats. Nephrology (Carlton 14 1 (2009) 80-85